Targeting the unmet medical need in Parkinson's Disease - the fastest growing neurological disorder. Sent on 15 April 2021
Gene therapies for body and brain in Duchenne Muscular Dystrophy, progress moves forward. Sent on 08 March 2020
Announcing Transpharmation Poland! Sent on 08 February 2020
Psilocybin: the power of mental reorganisation Sent on 06 December 2020
The future's bright for the magic mushroom. Expansion to world class premises Sent on 04 November 2020
We are delighted to share our very exciting news with you!In January 2021, Transpharmation Ltd will be taking on additional laboratory and office space, operating from the first-class facilities at the renowned Discovery Park research centre in Kent.This location will become Transpharmation’s primary site. Multiple therapeutic indications Sent on 05 October 2020
Transpharmation Ltd celebrate 10 years in business. See our latest neuroinflammation study being presented at the Annual Alzheimer's Drug Discovery Foundation conference. Focus on pain Sent on 04 September 2020
September is pain awareness month and we are presenting our latest pain study 'The effect of a reduced streptozocin dose and social housing on well-being, mechanical hypersensitivity and burrowing behaviour in type-1 diabetic rodents' at the IASP virtual conference. |